Astrana Health (ASTH) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
13 May, 2026Business performance and growth
Achieved over 50% year-over-year growth last year, with continued profitability and strong free cash flow; Q1 results exceeded expectations, with free cash flow tripling and revenue growing over 40%-50%.
Recent acquisition of Prospect closed nine months ago, with integration ahead of schedule and operational synergies tracking at the high end of the $12M-$15M range.
Integrated 1,500+ employees and 600,000 members from Prospect into a unified operating and data platform, eliminating silos and standardizing care protocols.
Revenue synergies realized by combining payer contracts and improving cost trends, with Prospect’s medical cost trend improving faster than underwritten expectations.
Early impact from care model integration is visible, with full benefits expected over 18-24 months.
Operational and technology strategy
Unified data and application layers enable seamless care management, preventing patients from falling through the cracks and automating follow-ups.
AI and automation tools are built on a unified data substrate, allowing agents to act across the enterprise and streamline provider and payer workflows.
Provider-facing tools integrate quality, risk adjustment, and claims management, enabling real-time prior authorization and appointment scheduling.
AI-driven automation has led to 70% of prior authorizations being auto-approved within seconds, reducing administrative burden and improving patient access.
Automated care transition and follow-up processes help reduce readmissions and escalate cases to human teams when needed, contributing to a 70 basis point G&A improvement in Q1.
Market and regulatory environment
Medicare Advantage medical cost trend underwritten at 5.2% for the year, with actual performance better than expected across all lines of business.
Minimal impact from CMS changes to risk adjustment due to low reliance on unlinked chart reviews and audio-only calls; estimated 1.5% headwind versus 2.5% industry average if new rules are implemented.
Anticipates margin-neutral to margin-accretive years ahead, with further insulation from regulatory changes due to business model and coding practices.
Supports CMS’s move toward AI-driven risk adjustment models, expecting potential benefit from reduced coding burden and fairer payments.
Suggests using Medicare Advantage claims data for risk adjustment coefficients to better reflect actual provider and patient behavior.
Latest events from Astrana Health
- Q1 2026 revenue rose 56% to $965.1M, with adjusted EBITDA up 82% and strong free cash flow growth.ASTH
Q1 202611 May 2026 - Proxy covers director elections, auditor ratification, pay, equity plan, and strong governance.ASTH
Proxy filing17 Apr 2026 - Key votes include board elections, auditor ratification, and executive compensation approval.ASTH
Proxy filing17 Apr 2026 - Record growth, resilient margins, and AI-driven efficiency amid industry headwinds.ASTH
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Record revenue and EBITDA growth achieved, with robust 2026 outlook and Prospect integration.ASTH
Q4 20253 Mar 2026 - Q2 revenue up 40% and net income up 46% year-over-year, with 2024 guidance raised.ASTH
Q2 20242 Feb 2026 - Accelerating growth and profitability through technology, full risk contracts, and market expansion.ASTH
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q3 revenue up 37% to $478.7M; guidance raised after major acquisitions.ASTH
Q3 202415 Jan 2026 - $745M deal expands reach to 1.7M members, targeting $1.2B revenue in 2024.ASTH
M&A Announcement15 Jan 2026